For years, JavaScript has reigned as the undisputed language of the web, powering everything from single-page apps to massive enterprise systems through frameworks like React, Angular, and Vue. But ...

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.” Isomorphic Labs, the UK-based biotech spinoff of ...

PCWorld highlights the Framework Laptop 13 Pro’s transformation into a premium device with solid aluminum construction, addressing previous models’ build quality issues while maintaining modular ...

Framework, the company that makes laptops designed for optimal repairability, announced a new version of its main product, a 13-inch-screen laptop. It’s called the Framework Laptop 13 Pro, and it has ...

Framework CEO Nirav Patel showed off his company’s latest modular, repairable laptops in San Francisco on Tuesday. The headliner is the new Laptop 13 Pro, which is its first machine fully machined out ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. The modular PC maker ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

The unified JavaScript runtime standard is an idea whose time has come. Here’s an inside look at the movement for server-side JavaScript interoperability. The WinterCG community group was recently ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.

Facepalm: A widely used web technology is affected by a serious security vulnerability that can be exploited with minimal effort to compromise servers. Known as "React2Shell," the flaw may require ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is trying to use artificial intelligence to understand biology and transform the way new medicines are discovered and developed. Bloomberg's Tom ...